Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chung-Feng Huang

Showing results (11-20 of 286) with videos related to

Pageof 29
Sort By:
Oncology|December 22, 2007
Long-term effects of interferon-based therapy for chronic hepatitis CMing-Lung Yu, Chung-Feng Huang, Chia-Yen Dai, et al.
Obesity Surgery|August 3, 2022
HBV Reactivation After Bariatric Surgery for HBV-Infected Obese PatientsChi-Ming Tai, Hung-Pin Tu, Jau-Chung Hwang, et al.
Expert Review of Gastroenterology & Hepatology|August 5, 2024
Metabolic dysfunction-associated steatotic liver disease and diabetes: the cross-talk between hepatologist and diabetologistMing-Lun Yeh, Jee-Fu Huang, Chia-Yen Dai, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2024
Chronic Hepatitis C Related Steatotic Liver Disease Is More Than "Miscellaneous Steatotic Liver Disease"Chung-Feng Huang, Ming-Lun Yeh, Chia-Yen Dai, et al.
The Kaohsiung Journal of Medical Sciences|January 3, 2012
Potential risk factors for the reactivation of the replication of hepatitis B and C viruses after transcatheter arterial chemoembolization of hepatocellular carcinomaChia-I Lin, Zu-Yau Lin, Ming-Yen Hsieh, et al.
Expert Review of Anti-Infective Therapy|November 7, 2018
Updates in the management and treatment of HCV genotype 3, what are the remaining challenges?Jee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 10, 2014
Comparison of the Abbott RealTime HBV assay with the Roche Cobas AmpliPrep/Cobas TaqMan HBV assay for HBV DNA detection and quantificationMing-Lun Yeh, Chung-Feng Huang, Ming-Yen Hsieh, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 24, 2022
Clinical characteristics and treatment outcomes of SARS-CoV-2 delta variant outbreak, Pingtung, Taiwan, June 2021Tyng-Yuan Jang, Hsin-Hui Wang, Chung-Feng Huang, et al.
Biomedicines|October 23, 2021
The Impact of Steatosis on Chronic Hepatitis C Progression and Response to Antiviral TreatmentsPhumelele Yvonne Siphepho, Yi-Ting Liu, Ciniso Sylvester Shabangu, et al.
Journal of the Chinese Medical Association : JCMA|June 5, 2018
A real world cost effectiveness analysis of interferon-based therapy for HCV naïve super-respondersPei-Chien Tsai, Ta-Wei Liu, Chung-Feng Huang, et al.
Pageof 29

Showing results (11-20 of 286) with videos related to

Sort By:
Pageof 29
Oncology|December 22, 2007
Long-term effects of interferon-based therapy for chronic hepatitis CMing-Lung Yu, Chung-Feng Huang, Chia-Yen Dai, et al.
Obesity Surgery|August 3, 2022
HBV Reactivation After Bariatric Surgery for HBV-Infected Obese PatientsChi-Ming Tai, Hung-Pin Tu, Jau-Chung Hwang, et al.
Expert Review of Gastroenterology & Hepatology|August 5, 2024
Metabolic dysfunction-associated steatotic liver disease and diabetes: the cross-talk between hepatologist and diabetologistMing-Lun Yeh, Jee-Fu Huang, Chia-Yen Dai, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2024
Chronic Hepatitis C Related Steatotic Liver Disease Is More Than "Miscellaneous Steatotic Liver Disease"Chung-Feng Huang, Ming-Lun Yeh, Chia-Yen Dai, et al.
The Kaohsiung Journal of Medical Sciences|January 3, 2012
Potential risk factors for the reactivation of the replication of hepatitis B and C viruses after transcatheter arterial chemoembolization of hepatocellular carcinomaChia-I Lin, Zu-Yau Lin, Ming-Yen Hsieh, et al.
Expert Review of Anti-Infective Therapy|November 7, 2018
Updates in the management and treatment of HCV genotype 3, what are the remaining challenges?Jee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 10, 2014
Comparison of the Abbott RealTime HBV assay with the Roche Cobas AmpliPrep/Cobas TaqMan HBV assay for HBV DNA detection and quantificationMing-Lun Yeh, Chung-Feng Huang, Ming-Yen Hsieh, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 24, 2022
Clinical characteristics and treatment outcomes of SARS-CoV-2 delta variant outbreak, Pingtung, Taiwan, June 2021Tyng-Yuan Jang, Hsin-Hui Wang, Chung-Feng Huang, et al.
Biomedicines|October 23, 2021
The Impact of Steatosis on Chronic Hepatitis C Progression and Response to Antiviral TreatmentsPhumelele Yvonne Siphepho, Yi-Ting Liu, Ciniso Sylvester Shabangu, et al.
Journal of the Chinese Medical Association : JCMA|June 5, 2018
A real world cost effectiveness analysis of interferon-based therapy for HCV naïve super-respondersPei-Chien Tsai, Ta-Wei Liu, Chung-Feng Huang, et al.
Pageof 29